
Wolfgang joined Apheon in 2005 and has been involved in several transactions, including Fiabila, Fair Doctors, VidaCura, Telenco, Haudecoeur, Saverto, svt, Keesing, opseo, Looping, Sausalitos, Elitech, Larcier Holding, De Boeck Education, ZellBios, Joris Ide, Corialis and King Benelux. He is also independent board member of VPK Group, D’Ieteren and Immobel. Prior to joining Apheon, he was CEO of Laboratoires Sterop Pharmacobel. He spent most of his career in investment banking at Lehman Brothers in NY and London, where he culminated as co-head of the European M&A Healthcare team. Wolfgang holds an MBA from the University of Chicago (US) and a Master of Science in Applied Economics and Management from the Louvain School of Management (Belgium). Wolfgang is fluent in French, English and Dutch.
Our manifesto: contributing to the development of sustainable finance
To succeed with this strategy, Apheon believes a holistic and collective approach is fundamental.
Holistic: it is essential that all aspects of ESG are equally and continuously supported. This is why we are active at every stage of the investment cycle by applying proprietarily developed methodologies and initiatives which are built on 5 priorities covering the broad ESG spectrum: